We are live on ! Find out more
DCLA

Douglas C. Lane & Associates Portfolio holdings

AUM $3.69B
1-Year Est. Return 0.11%
This Fund
S&P 500
This Quarter Est. Return
-0.45%
1 Year Est. Return
+0.11%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.35B
AUM Growth
+$41.9M
Cap. Flow
+$91.4M
Cap. Flow %
2.73%
Top 10 Hldgs %
20.42%
Holding
248
New
25
Increased
103
Reduced
91
Closed
15

Top Buys

Rank Stock Value
1
MET icon
MetLife
MET
+$14.9M
2
DINO icon
HF Sinclair
DINO
+$8.26M
3
SSYS icon
Stratasys
SSYS
+$7.67M
4
VLO icon
Valero Energy
VLO
+$7.25M
5
MPC icon
Marathon Petroleum
MPC
+$6.33M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$17.8M
2
KO icon
Coca-Cola
KO
+$6.05M
3
MMM icon
3M
MMM
+$5.98M
4
HRI icon
Herc Holdings
HRI
+$5.57M
5
WBD icon
Warner Bros
WBD
+$5.26M

Sector Composition

Rank Sector Weight
1 Industrials 19.4%
2 Technology 15.85%
3 Healthcare 15.09%
4 Consumer Discretionary 10.88%
5 Financials 5.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KO icon
76
Coca-Cola
KO
$375B
$17M 0.51%
398,292
-146,435
-27% -$6.05M
DGI
77
DELISTED
DigitalGlobe Inc.
DGI
$16.9M 0.51%
593,954
+173,990
+41% +$5.06M
MMM icon
78
3M
MMM
$94.3B
$16.1M 0.48%
136,138
-49,724
-27% -$5.98M
AVB icon
79
AvalonBay Communities
AVB
$26.8B
$15.4M 0.46%
109,482
+1,606
+1% +$238K
DINO icon
80
HF Sinclair
DINO
$14.5B
$15.3M 0.46%
350,413
+177,075
+102% +$8.26M
GEN icon
81
Gen Digital
GEN
$17.5B
$15.3M 0.46%
649,017
-75,577
-10% -$1.8M
MET icon
82
MetLife
MET
$62.4B
$15.3M 0.46%
318,601
+306,027
+2,434% +$14.9M
ZTS icon
83
Zoetis
ZTS
$30.5B
$14.4M 0.43%
389,591
+182,921
+89% +$6.26M
LAMR icon
84
Lamar Advertising Co
LAMR
$16.3B
$14.3M 0.43%
289,883
-5,960
-2% -$307K
CL icon
85
Colgate-Palmolive
CL
$74.4B
$13.3M 0.4%
204,393
+1,040
+0.5% +$68.6K
HON icon
86
Honeywell
HON
$78B
$12.5M 0.37%
149,089
+10,522
+8% +$894K
JNJ icon
87
Johnson & Johnson
JNJ
$625B
$12.3M 0.37%
115,868
-4,680
-4% -$485K
WFM
88
DELISTED
Whole Foods Market Inc
WFM
$12.2M 0.37%
321,013
+121,111
+61% +$4.63M
NVO
89
Novo Nordisk
NVO
$209B
$11.5M 0.34%
481,986
+140,744
+41% +$3.24M
SBUX icon
90
Starbucks
SBUX
$120B
$11.3M 0.34%
299,670
-9,360
-3% -$362K
DISCK
91
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$11M 0.33%
294,725
+43,843
+17% +$1.77M
CVX icon
92
Chevron
CVX
$366B
$10.6M 0.32%
88,622
-12,452
-12% -$1.59M
LLTC
93
DELISTED
Linear Technology Corp
LLTC
$9.93M 0.3%
223,643
-20,902
-9% -$949K
CLB icon
94
Core Laboratories
CLB
$521M
$9.75M 0.29%
66,607
+40,292
+153% +$6.22M
AAL icon
95
American Airlines Group
AAL
$10.6B
$9.74M 0.29%
274,538
+73,865
+37% +$2.91M
LVLT
96
DELISTED
Level 3 Communications Inc
LVLT
$9.7M 0.29%
212,138
+134,490
+173% +$5.97M
PG icon
97
Procter & Gamble
PG
$339B
$9.41M 0.28%
112,401
-14,086
-11% -$1.15M
NLSN
98
DELISTED
Nielsen Holdings plc
NLSN
$9.07M 0.27%
204,690
+17,750
+9% +$834K
VOD icon
99
Vodafone
VOD
$37.4B
$8.96M 0.27%
272,303
-44,578
-14% -$1.49M
META icon
100
Meta Platforms (Facebook)
META
$1.51T
$8.53M 0.25%
107,899
+5,750
+6% +$422K
2 3
4
5 6

Similar funds

AM
Appaloosa Management Miami Beach, Florida $5.01B AUM 0.22% 1-Year Est. Return
NRECA
National Rural Electric Cooperative Association Arlington, Virginia $5.58B AUM 0.17% 1-Year Est. Return
ALA
Atherton Lane Advisers Menlo Park, California $1.72B AUM 0.32% 1-Year Est. Return
KIG
Kovitz Investment Group Chicago, Illinois $1.62B AUM 5.44% 1-Year Est. Return
GC
GW Capital Bellevue, Washington $1.44B AUM 5.7% 1-Year Est. Return
CC
Curian Capital Denver, Colorado $1.35B AUM 0.33% 1-Year Est. Return
CC
Chubb Corp Warren, New Jersey $1.24B AUM 0.59% 1-Year Est. Return
AC
Apex Capital Orinda, California $938M AUM 4.67% 1-Year Est. Return

Douglas C. Lane & Associates's Q3 2014 Portfolio in Review

As of Q3 2014, Douglas C. Lane & Associates held 248 positions worth $3.35B, up 1.3% from $3.31B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Douglas C. Lane & Associates's Q3 2014 filing shows 25 new, 103 increased, 91 reduced and 15 closed positions. Its largest new stake was Stratasys: 67,832 shares worth $8.19M. The largest sale was AbbVie, an estimated $17.8M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.

  • Douglas C. Lane & Associates's largest Q3 2014 buy was Stratasys: 67,832 shares worth $8.19M.
  • Douglas C. Lane & Associates added most to MetLife in Q3 2014, an estimated $14.9M increase.
  • Douglas C. Lane & Associates's biggest Q3 2014 reduction was AbbVie, cutting an estimated $17.8M.
  • Douglas C. Lane & Associates fully exited Carbo Ceramics Inc. in Q3 2014, selling an estimated $2.28M.
  • Douglas C. Lane & Associates's ten largest holdings make up 20% of its $3.35B portfolio in Q3 2014.
  • Douglas C. Lane & Associates opened 25 new positions and closed 15 in Q3 2014.
  • Douglas C. Lane & Associates's portfolio value rose 1.3% quarter-over-quarter to $3.35B.

Based on Douglas C. Lane & Associates's 13F filing for Q3 2014, filed 27 Oct 2014.